In a recent medium.com blog post, Daphne Koller, an artificial intelligence researcher at the Department of Computer Science at Stanford University,  announced her up-and-coming foray into machine learning-powered drug discovery. Called insitro, the new endeavour looks to stem the increasing costs of developing new drugs.